- Home
- NAGE vs INGN Comparison
NAGE vs INGN Comparison
Compare NAGE & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAGE | INGN |
|---|---|---|
| Founded | 1999 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 212.8M | 177.0M |
| IPO Year | 2010 | 2013 |
Fundamental Metrics
Financial Performance| Metric | NAGE | INGN |
|---|---|---|
| Price | $2.43 | $7.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $12.08 | $12.00 |
| AVG Volume (30 Days) | ★ 521.4K | 328.3K |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 81.82 | 43.42 |
| EPS | ★ 0.09 | N/A |
| Revenue | $129,423,000.00 | ★ $348,668,000.00 |
| Revenue This Year | $2.85 | $2.22 |
| Revenue Next Year | $16.67 | $4.55 |
| P/E Ratio | $27.83 | ★ N/A |
| Revenue Growth | ★ 29.95 | 3.86 |
| 52 Week Low | $2.43 | $5.05 |
| 52 Week High | $7.95 | $8.94 |
Technical Indicators
Market Signals| Indicator | NAGE | INGN |
|---|---|---|
| Relative Strength Index (RSI) | 29.44 | 75.54 |
| Support Level | N/A | $6.01 |
| Resistance Level | $3.61 | $7.55 |
| Average True Range (ATR) | 0.08 | 0.25 |
| MACD | -0.01 | 0.10 |
| Stochastic Oscillator | 2.99 | 93.79 |
Price Performance
Historical ComparisonAbout NAGE Niagen Bioscience Inc.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
About INGN Inogen Inc
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.